Cholangiocarcinoma: Update and future perspectives
Authors:
- Maria Consiglia BragazziMBMaria Consiglia Bragazzi
- Rossella SemeraroRSRossella Semeraro
- Cristina NapoliCNCristina Napoli
- Raffaele GentileRGRaffaele Gentile
- Alessia TorriceATAlessia Torrice
- Eugenio GaudioEGEugenio Gaudio
- Domenico AlvaroDADomenico Alvaro
- 1 April 2010
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 42 (4) , 253-260
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2†Hepatology, 2009
- Increased local dopamine secretion has growth‐promoting effects in cholangiocarcinomaInternational Journal of Cancer, 2009
- Biliary intraepithelial neoplasia in patients without chronic biliary diseaseCancer, 2009
- Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinomaBritish Journal of Cancer, 2009
- Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factorDigestive and Liver Disease, 2009
- Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infectionHepatology, 2008
- CholangiocarcinomaHepatology, 2008
- Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatmentJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factorsJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001British Journal of Cancer, 2006